Identification of subgroups of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone plus prednisone at low- vs. high-risk of radiographic progression: An analysis of COU-AA-302

INTRODUCTION: Radiographic imaging is used to monitor disease progression for men with metastatic castrate-resistant prostate cancer (mCRPC). The optimal frequency of imaging, a costly and limited resource, is not known. Our objective was to identify predictors of radiographic progression to inform...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Can Urol Assoc J
Main Authors: Martin, Lisa J., Alibhai, Shabbir M.H., Komisarenko, Maria, Timilshina, Narhari, Finelli, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: Canadian Medical Association 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6570594/
https://ncbi.nlm.nih.gov/pubmed/30407155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.5586
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados